Literature DB >> 6273871

Episomal simian virus 40 genomes in human brain tumors.

P Krieg, E Amtmann, D Jonas, H Fischer, K Zang, G Sauer.   

Abstract

Eight out of 35 human intracranial tumors were shown by restriction enzyme analysis to contain unintegrated simian virus 40 (SV40) DNA molecules. The relative amount of viral DNA was estimated to be the equivalent of one viral genome within every 10th to 20th cell. No infectious virus was detected in tissue cultures established from the tumors. From only one tumor was it possible to rescue, by cell fusion, infectious SV40 displaying wild-type properties. In those cases that permitted a more detailed analysis, the restriction enzyme cleavage patterns appeared to correspond to the wild-type patterns with one exception, in which the SV40 episomes displayed a deletion of approximately 70 base pairs close to the origin of DNA replication. From one tumor, the SV40 genomes were transferred into permissive CV-1 monkey cells by transfection with the total tumor DNA. Despite their persistence as episomes no infectious virus was produced. Furthermore, no viral antigens were detectable, although the SV40 messengers for the small and the large tumor antigens were present. These cells had, however, acquired the ability to form colonies in low concentrations of serum. Thus this report provides, by restriction enzyme analysis, direct evidence for the presence of SV40 DNA in human tumors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273871      PMCID: PMC349056          DOI: 10.1073/pnas.78.10.6446

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Malignant transformation of hamster kidney cells by BK virus.

Authors:  M Portolani; G Barbanti-Brodano; M L Placa
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

2.  Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route.

Authors:  J A MORRIS; K M JOHNSON; C G AULISIO; R M CHANOCK; V KNIGHT
Journal:  Proc Soc Exp Biol Med       Date:  1961-10

3.  Simian virus 40 in a human cancer.

Authors:  F Soriano; C E Shelburne; M Gökcen
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

4.  Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome.

Authors:  P A Sharp; U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1974-07-15       Impact factor: 5.469

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

7.  Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome.

Authors:  K K Takemoto; A S Rabson; M F Mullarkey; R M Blaese; C F Garon; D Nelson
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

8.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

9.  Comparison of two human papovaviruses with simian virus 40 by structural protein and antigenic analysis.

Authors:  M F Mullarkey; J F Hruska; K K Takemoto
Journal:  J Virol       Date:  1974-05       Impact factor: 5.103

10.  Malignant transformation of BHK21 clone 13 cells by BK virus--a human papovavirus.

Authors:  E O Major; G Di Mayorca
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

View more
  25 in total

1.  Physiological and cytogenetic characterization of immortalized human endometriotic cells containing episomal simian virus 40 DNA.

Authors:  A Akoum; J Lavoie; R Drouin; C Jolicoeur; A Lemay; R Maheux; E W Khandjian
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 2.  Brain tumors and polyomaviruses.

Authors:  Sidney Croul; Jessica Otte; Kamel Khalili
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

3.  Simian virus 40 infection of humans.

Authors:  Robert L Garcea; Michael J Imperiale
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Postmitotic nuclear retention of episomal plasmids is altered by DNA labeling and detection methods.

Authors:  Joshua Z Gasiorowski; David A Dean
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

5.  Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen.

Authors:  R L Mernaugh; M H Shearer; R K Bright; R E Lanford; R C Kennedy
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease.

Authors:  J A Lednicky; A S Arrington; A R Stewart; X M Dai; C Wong; S Jafar; M Murphey-Corb; J S Butel
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Fetal origin of the medulloblastoma: evidence from growth analysis of two cases.

Authors:  K Hirakawa; K Suzuki; S Ueda; J Handa
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expression.

Authors:  R K Bright; M H Shearer; R C Kennedy
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

Review 9.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 10.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.